{"transactions":[{"id":806830,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-04-17T00:15:26.000Z","date":"2026-04-14","kind":"grant","planned":false,"acquired":true,"shares":1572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors."}],"balance_after":4324,"source":{"system":"sec-edgar","filing":"0001437749-26-012588","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774926012588/rdgdoc.xml","form_type":"4"}},{"id":1140018,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-20T21:22:33.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":1572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors."}],"balance_after":2752,"source":{"system":"sec-edgar","filing":"0001437749-25-017867","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774925017867/rdgdoc.xml","form_type":"4"}},{"id":1548565,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-04-03T13:00:16.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":2000,"derivative":{"exercise_price":0.93,"exercise_date":"2024-03-29","expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001437749-24-010748","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774924010748/rdgdoc.xml","form_type":"4"}},{"id":1548564,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-03T13:00:16.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2024, September 30, 2024, December 31, 2024 and March 31, 2025. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024."}],"balance_after":9438,"source":{"system":"sec-edgar","filing":"0001437749-24-010748","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774924010748/rdgdoc.xml","form_type":"4"}},{"id":1998512,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2023-02-22T21:30:05.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":30000,"derivative":{"exercise_price":0.28,"exercise_date":"2023-02-17","expiration_date":"2028-02-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-23-004161","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774923004161/rdgdoc.xml","form_type":"4"}},{"id":1998511,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-22T21:30:05.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted shares of common stock were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted shares of common stock vest quarterly in equal increments on June 30, 2023, September 30, 2023, December 31, 2023 and March 31, 2024, subject to continued service as a director of the Issuer on each applicable vesting date."}],"balance_after":17531,"source":{"system":"sec-edgar","filing":"0001437749-23-004161","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000143774923004161/rdgdoc.xml","form_type":"4"}},{"id":2296209,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-15T21:30:45.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The stock options are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."}],"balance_after":30000,"derivative":{"exercise_price":0.818,"exercise_date":"2022-03-11","expiration_date":"2027-03-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001654954-22-005072","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495422005072/section16.xml","form_type":"4"}},{"id":2296208,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-15T21:30:45.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The restricted stock units vest quarterly in equal increments on June 30, 2022, September 30, 2022, December 31, 2022 and March 31, 2023, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022."}],"balance_after":12531,"source":{"system":"sec-edgar","filing":"0001654954-22-005072","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495422005072/section16.xml","form_type":"4"}},{"id":2547931,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Common stock","published_at":"2021-10-05T17:43:07.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021."}],"balance_after":7531,"source":{"system":"sec-edgar","filing":"0001654954-21-010809","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421010809/section16.xml","form_type":"4/A","original_submission_date":"2021-03-16"}},{"id":2788669,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-03-16T00:56:48.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":4.4,"exercise_date":"2021-03-12","expiration_date":"2026-03-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001654954-21-002824","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002824/section16.xml","form_type":"4"}},{"id":2788668,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Restricted stock award","published_at":"2021-03-16T00:56:48.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":1250,"price":4.4,"value":5500.0,"ownership":{"direct":true},"balance_after":1250,"derivative":{"exercise_price":0,"exercise_date":"2022-03-12","expiration_date":"2022-03-12","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001654954-21-002824","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002824/section16.xml","form_type":"4"}},{"id":2788667,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Restricted stock award","published_at":"2021-03-16T00:56:48.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":1250,"price":4.4,"value":5500.0,"ownership":{"direct":true},"balance_after":1250,"derivative":{"exercise_price":0,"exercise_date":"2021-12-31","expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001654954-21-002824","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002824/section16.xml","form_type":"4"}},{"id":2788666,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Restricted stock award","published_at":"2021-03-16T00:56:48.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":1250,"price":4.4,"value":5500.0,"ownership":{"direct":true},"balance_after":1250,"derivative":{"exercise_price":0,"exercise_date":"2021-09-30","expiration_date":"2021-09-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001654954-21-002824","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002824/section16.xml","form_type":"4"}},{"id":2788665,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Restricted stock award","published_at":"2021-03-16T00:56:48.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":1250,"price":4.4,"value":5500.0,"ownership":{"direct":true},"balance_after":1250,"derivative":{"exercise_price":0,"exercise_date":"2021-06-30","expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001654954-21-002824","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495421002824/section16.xml","form_type":"4"}},{"id":3053459,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-08-18T21:00:43.000Z","date":"2020-08-14","kind":"sale","acquired":false,"shares":10000,"price":3.43,"value":34300.0,"ownership":{"direct":true},"balance_after":2531,"source":{"system":"sec-edgar","filing":"0001654954-20-009310","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420009310/section16.xml","form_type":"4"}},{"id":3131685,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2020-05-28T20:43:10.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":1.57,"exercise_date":"2020-05-27","expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-20-006043","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420006043/section16.xml","form_type":"4"}},{"id":3309170,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"common stock","published_at":"2020-01-16T12:02:11.000Z","date":"2020-01-14","kind":"purchase","acquired":true,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":true},"balance_after":12531,"source":{"system":"sec-edgar","filing":"0001654954-20-000507","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495420000507/section16.xml","form_type":"4"}},{"id":3529091,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Stock Option","published_at":"2019-05-13T16:21:41.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":5.41,"exercise_date":"2019-05-09","expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-19-005740","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495419005740/section16.xml","form_type":"4"}},{"id":3839336,"issuer":{"id":8230,"kind":"organization","name":"cbdMD, Inc."},"owners":[{"id":52228,"kind":"person","name":"Sellers Bakari T.","position":1,"cik":"0001721556","reported_name":"Sellers Bakari T.","relationship":{"director":true}}],"security":"Options grant","published_at":"2018-08-17T20:30:41.000Z","date":"2018-08-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7000,"derivative":{"exercise_price":3.34,"exercise_date":"2018-08-16","expiration_date":"2028-08-16","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001654954-18-009323","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644903/000165495418009323/section16.xml","form_type":"4"}}]}